Systemic Chemotherapy with Cisplatin Plus 5-FU (PF) for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN): Efficacy and Safety of a Lower Dose of PF (80/800) at a Single Institution in Japan

Naomi Kiyota1 Makoto Tahara1 Shigenori Kadowaki1 Nozomu Fuse1 Toshihiko Doi1 Hironobu Minami2 and Atsushi Ohtsu1

首页> 外文期刊>Japanese Journal of Clinical Oncology >Systemic Chemotherapy with Cisplatin Plus 5-FU (PF) for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN): Efficacy and Safety of a Lower Dose of PF (80/800) at a Single Institution in Japan

【24h】

Systemic Chemotherapy with Cisplatin Plus 5-FU (PF) for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN): Efficacy and Safety of a Lower Dose of PF (80/800) at a Single Institution in Japan

机译：顺铂加5-FU（PF）用于复发性或转移性头颈部鳞状细胞癌（R / M SCCHN）的系统化学疗法：在日本的一家机构中，小剂量PF（80/800）的疗效和安全性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Japanese Journal of Clinical Oncology》 |2009年第4期|p.225-230|共6页
作者
Naomi Kiyota1 Makoto Tahara1 Shigenori Kadowaki1 Nozomu Fuse1 Toshihiko Doi1 Hironobu Minami2 and Atsushi Ohtsu1;
展开▼
作者单位

1Division of Digestive Endoscopy and Gastrointestinal Oncology, National Cancer Center Hospital East 2Division of Oncology/Hematology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
专利

1. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan. [J] . Kiyota N, Tahara M, Kadowaki S Japanese journal of clinical oncology. . 2009,第4期

机译：顺铂加5-FU（PF）进行的全身化学疗法治疗复发或转移性头颈部鳞状细胞癌（R / M SCCHN）：在日本一家机构中使用较低剂量的PF（80/800）的疗效和安全性。
2. 97 Phase I study of cetuximab (C225)in combination with cisplatin or carboplatin and 5-fluorouracil (5-FU) in patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R&M SCCHN) [J] . J.Bourhis, F.Rivera, R.Mesia, European Journal of Cancer Supplements . 2003,第5期

机译：97西妥昔单抗（C225）与顺铂或卡铂和5-氟尿嘧啶（5-FU）联合用于头颈部复发和/或转移性鳞状细胞癌（R＆M SCCHN）患者（pts）的I期研究
3. Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC). [J] . Rivera F, Vega-Villegas ME, Lopez-Brea M, Cancer chemotherapy and pharmacology. . 2008,第2期

机译：顺铂和5-FU连续输注（PF）与顺铂，UFT和长春瑞滨（UFTVP）作为局部晚期鳞状细胞癌和头颈癌（LA-SCHNC）诱导化疗的随机II期研究。
4. CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma [C] . Zhien Feng, Lizhen Wang, Bingshun Wang, Academic Committee Conference of Shanghai key lab of stomatology . 2011

机译：CCND1作为局部晚期头颈部鳞状细胞癌患者新辅助化疗的预测生物标志物
5. Inflammatory mechanisms of chemokine receptor 7 expression in metastatic squamous cell carcinoma of the head and neck (SCCHN). [D] . Mburu, Yvonne K. 2011

机译：趋化因子受体7在头颈部转移性鳞状细胞癌（SCCHN）中表达的炎症机制。
6. Meta-analysis of clinical trials comparing the efficacy and safety of liposomal cisplatin versus conventional nonliposomal cisplatin in nonsmall cell lung cancer (NSCLC) and squamous cell carcinoma of the head and neck (SCCHN) [O] . Bei Xu, Min Zeng, Jiawei Zeng, -1

机译：荟萃分析比较了脂质体顺铂与常规非脂质体顺铂在非小细胞肺癌（NSCLC）和头颈部鳞状细胞癌（SCCHN）中的疗效和安全性
7. Systemic Chemotherapy with Cisplatin Plus 5-FU (PF) for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN): Efficacy and Safety of a Lower Dose of PF (80/800) at a Single Institution in Japan [O] . Naomi Kiyota, Makoto Tahara, Shigenori Kadowaki, 2008

机译：顺铂加5-FU（pF）用于头颈部复发或转移性鳞状细胞癌的系统化疗（R / m sCCHN）：日本单一机构的低剂量pF（80/800）的功效和安全性

Systemic Chemotherapy with Cisplatin Plus 5-FU (PF) for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN): Efficacy and Safety of a Lower Dose of PF (80/800) at a Single Institution in Japan

著录项

相似文献

相关主题

期刊订阅